Products
Dr Falk Pharma UK is dedicated to improving patient outcomes through advancing the understanding and treatment of digestive and metabolic diseases. View our comprehensive product range below.
The following pages contain comprehensive information on the Dr Falk Pharma product range. We produce four different therapies designed to treat inflammatory bowel conditions, Eosinophilic Oesophagitis and Cholestatic Liver Disease.
-
Budenofalk
Budenofalk (budesonide) is a topical steroid used to treat Crohn’s Disease, Microscopic Colitis and Autoimmune Hepatitis (oral formulations) and also Ulcerative Colitis (rectal formulation).
-
Salofalk
Salofalk (mesalazine) is used to treat Ulcerative Colitis and is available in a range of oral and rectal formulations.
-
Ursofalk
Ursofalk (ursodeoxycholic acid) is an oral medicine used to treat Primary Biliary Cholangitis (PBC), Cholesterol Gallstones, hepatobiliary disorders associated with Cystic Fibrosis. Available as capsules, tablets and suspension.
-
Jorveza
Jorveza (budesonide) is an oral treatment for the induction and maintenance of remission in patients with Eosinophilic Esophagitis (EoE) in adults.
This information on the following pages is intended only for UK and Irish residents who have been prescribed either Budenofalk, Salofalk, Ursofalk or Jorveza.